Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Enter your registration information

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Ambit Biosciences IPO Newsletter

Turning Point Prices IPO, Raising $166M to Test Cancer Drugs 17 Apr 2019 17:14 GMT
… investors’s appetite for biotech IPOs. Earlier this year in … $276 million in an IPO that also surpassed expectations. … , at San Diego’s Ambit Biosciences, led clinical development of quizartinib … Prior to Turning Point’s IPO, the company has raised …
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease 01 Mar 2019 00:35 GMT
… about $65 million in an initial public offering in October just 19 months … took it from inception to IPO in less than two years … head of corporate development at Ambit Biosciences. (BioMed was acquired in 2016 …
BioMarin Announces Governance Enhancements and Value Creation Initiatives 21 Dec 2023 10:20 GMT
… Chief Executive Officer through its initial public offering (IPO) to its eventual acquisition by … of Ambit Biosciences, where she helped lead the company's IPO and …
Tyra Biosciences Announces Planned Chief Financial Officer Transition 02 Nov 2022 00:00 GMT
… of Ambit Biosciences, where he helped lead the company through its initial public offering and …

Continue to create your account.